Vaccines Market to Be Worth $57.5 Billion by 2025 - Exclusive Report by Meticulous Research®

LONDON, July 25, 2019 (Newswire.com) - ​Meticulous Research^® published the latest market research report on the highly intriguing industry segment, “Vaccines”, in the past week. The report states that the global Vaccines market will increase at a CAGR of 7.9% from 2018 to reach $57.5 billion by 2025, driven by the high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in the vaccine industry, and a strong pipeline for vaccines.

The report provides meticulous analysis of this market by segmenting it on the basis of indications (pneumococcal disease, influenza, DTP, polio, HPV, MMR, rotavirus, meningococcal disease, hepatitis, and others), route of administration (intramuscular (IM), subcutaneous (SC/SQ), oral, and other), and type of vaccines (subunit, recombinant, polysaccharide, and conjugate), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa).

Please download the report and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4813

Geographically, North America commanded the largest share in this market, followed by Europe. The major share of North America is mainly attributed to its well-established vaccination programs, increasing prevalence of diseases, growing adoption of advanced vaccines, and a large pool of key players.

“Despite North America being the largest market for Vaccines, it is the Asia-Pacific region that is set to register the fastest growth rate, majorly due to the increasing number of diseases and viruses, the large population of patients, public awareness, and governmental support towards awareness and development of new vaccines,” said Uddhav Sable, Research Director at Meticulous Research.

Among the indications, the pneumococcal disease segment commanded the largest share in this market, majorly due to the high prevalence of pneumococcal disease in pediatric, elderly, and immune-compromised populations. In addition, the growing number of pneumococcal diseases resulting in chronic illnesses is further driving the adoption of the pneumococcal vaccines globally.

The key players analyzed in the global Vaccines market are GSK, Merck & Co., Inc., Pfizer, Sanofi, CSL Limited, Emergent BioSolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda, and AstraZeneca.

The report is available for purchase in electronic format with multiple license choices and sectional purchases, starting from $499 only.

Request Sample or Check for Discount: https://www.meticulousresearch.com/request-discount/cp_id=4813

Scope of the Report:

Vaccines Market by Indication

• Pneumococcal Disease
• Influenza
• DTP
• Polio
• HPV
• MMR
• Rotavirus
• Meningococcal Disease
• Hepatitis
• Others

Vaccines Market by Route of Administration

• Intramuscular (IM)
• Subcutaneous (SC/SQ)
• Oral
• Others (Intradermal and Nasal).

Vaccines Market by Type

• Subunit, recombinant, polysaccharide, and conjugate vaccines
• Inactivated vaccines
• Live-attenuated vaccines
• Toxoid vaccines.

Vaccines Market by Valent

• Monovalent
• Multivalent

Vaccines Market by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • U.K.
  • Italy
  • Rest of Europe (RoE)
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • Rest of APAC (RoAPAC)
• Latin America
• Middle East and Africa

Please download the report and learn more: https://www.meticulousresearch.com/download-sample-report/cp_id=4813

Source: Meticulous Market Research Pvt. Ltd.